Sg Americas Securities, LLC Atara Biotherapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$0.44 - $1.22 $8,884 - $24,633	-20,191 Reduced 40.44%	29,733 $21,000
Q4 2023 Jan 12, 2024	BUY	$0.23 - $1.74 $2,571 - $19,454	11,181 Added 28.86%	49,924 $26,000
Q3 2023 Oct 13, 2023	BUY	$1.41 - $2.31 $54,627 - $89,496	38,743 New	38,743 $57,000
Q1 2023 Apr 28, 2023	BUY	$2.8 - $5.46 $21,817 - $42,544	7,792 Added 28.95%	34,707 $101,000
Q4 2022 Feb 02, 2023	SELL	$2.85 - $5.18 $13,902 - $25,268	-4,878 Reduced 15.34%	26,915 $88,000
Q3 2022 Oct 31, 2022	SELL	$2.85 - $8.73 $100,941 - $309,199	-35,418 Reduced 52.7%	31,793 $120,000
Q2 2022 Jul 29, 2022	SELL	$4.69 - $9.84 $652,674 - $1.37 Million	-139,163 Reduced 67.43%	67,211 $524,000
Q1 2022 Apr 29, 2022	SELL	$8.44 - $16.89 $101,111 - $202,342	-11,980 Reduced 5.49%	206,374 $1.92 Million
Q4 2021 Feb 07, 2022	SELL	$14.7 - $19.89 $468,915 - $634,471	-31,899 Reduced 12.75%	218,354 $3.44 Million
Q3 2021 Nov 01, 2021	BUY	$11.99 - $17.9 $617,808 - $922,333	51,527 Added 25.93%	250,253 $4.48 Million
Q2 2021 Aug 12, 2021	BUY	$12.89 - $16.58 $1.55 Million - $2 Million	120,566 Added 154.26%	198,726 $3.09 Million
Q1 2021 May 13, 2021	BUY	$14.0 - $20.72 $895,818 - $1.33 Million	63,987 Added 451.47%	78,160 $1.12 Million
Q4 2020 Feb 04, 2021	SELL	$12.67 - $26.23 $174,592 - $361,449	-13,780 Reduced 49.3%	14,173 $278,000
Q3 2020 Nov 09, 2020	BUY	$11.92 - $15.87 $333,199 - $443,614	27,953 New	27,953 $362,000
Q2 2020 Jul 20, 2020	SELL	$7.53 - $14.93 $81,534 - $161,662	-10,828 Closed	0 $0
Q1 2020 Apr 30, 2020	BUY	$5.69 - $17.78 $16,244 - $50,761	2,855 Added 35.81%	10,828 $92,000
Q4 2019 Jan 28, 2020	BUY	$10.89 - $16.79 $86,825 - $133,866	7,973 New	7,973 $131,000
Q2 2019 Jul 29, 2019	SELL	$19.05 - $41.04 $198,729 - $428,129	-10,432 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$28.4 - $41.74 $14,285 - $20,995	503 Added 5.07%	10,432 $415,000
Q4 2018 Feb 01, 2019	BUY	$30.9 - $42.97 $225,755 - $313,938	7,306 Added 278.54%	9,929 $345,000
Q3 2018 Nov 06, 2018	BUY	$35.05 - $43.5 $91,936 - $114,100	2,623 New	2,623 $108,000
Q2 2018 Aug 07, 2018	SELL	$35.15 - $51.45 $96,627 - $141,436	-2,749 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$18.0 - $48.35 $49,482 - $132,914	2,749 New	2,749 $107,000
Q4 2017 Jan 24, 2018	SELL	$13.2 - $18.1 $112,899 - $154,809	-8,553 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$13.25 - $17.05 $113,327 - $145,828	8,553	8,553 $142,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account